No Data
No Data
Is Catalysts Pharmaceuticals, Inc. (CPRX) the Best Performing Biotech Stock in 2024?
BofA Securities Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating
PepGen Stock Craters 35% on FDA Clinical Hold
Catalyst Pharmaceuticals CEO Richard J. Daly to Present at 43rd Annual J.P. Morgan Healthcare Conference
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
We Ran A Stock Scan For Earnings Growth And Catalyst Pharmaceuticals (NASDAQ:CPRX) Passed With Ease